In one paragraphArticle in mBio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Mary Clark H LindDepartment of Microbiology and Immunology, School of Medicine, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA.ORCID 0000-0001-6060-6918 Waheeda A NaimiDepartment of Microbiology and Immunology, School of Medicine, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA.
Jason R HuntDepartment of Microbiology and Immunology, School of Medicine, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA.
Jerilyn R IzacDepartment of Microbiology and Immunology, School of Medicine, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA.
Richard T MarconiDepartment of Microbiology and Immunology, School of Medicine, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA.ORCID 0000-0002-6035-7306 Jason A CarlyonDepartment of Microbiology and Immunology, School of Medicine, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA.ORCID 0000-0003-2778-5066 Funding
The roles of Anaplasma phagocytophilum surface proteins in infectionR01AI072683 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI CARLYON, JASON A · 2007 to 2021
$5.8MThe roles of ceramide and its derivatives in A. phagocytophilum pathogenesisR01AI139072 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI CHARLES E. CHALFANT, Jason A Carlyon · 2018 to 2026
$5.7MOrientia tsutsugamushi Ank-host interactions in scrub typhus pathogenesisR01AI167857 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI Jason A Carlyon · 2022 to 2026
$2.9MNIAID NIH HHS R01 AI072683NIAID NIH HHS R01 AI139072NIAID NIH HHS R01 AI167857
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Adhesins, BacterialAnaplasma phagocytophilumBacterial ProteinsCD18 AntigensEhrlichiosisHost-Pathogen InteractionsAnimalsFemaleHL-60 CellsHumansMiceNeoplasm ProteinsNeutrophilsProtein BindingAdhesins, BacterialAIPB protein, humanBacterial ProteinsCD18 AntigensNeoplasm ProteinsadhesinAnaplasmaAnaplasmataceaeCD18host-pathogen interactionsinvasinobligate intracellular bacteriaRickettsialesβ2 integrin
Identifiers
PMID41733347
PMCPMC13059740
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390